Keywords: AIDS; acquired immunodeficiency syndrome; AUC; area under the plasma concentration versus time curve of NVP in absence of NT; AUCI; area under the plasma concentration versus time curve of NVP in presence of NT; AUCratio; ratio between AUCI and AUC (AUCI/
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: α; apha; ALT; alanine aminotransferase; ANOVA; analysis of variance; AST; aspartate transaminase; β; beta; cART; combination antiretroviral therapy; C; control; DAB; liquid 3âµ3-diaminobenzidine; DPX; distyrene/plasticizer/xylene; EFV; efavirenz; eGFR;
Keywords: HIV; human immunodeficiency virus; RT; reverse transcriptase; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; WT; wild-type; K101P; Lysine101Proline; IC50; inhibition concentration at 50%; EC50; eff
Keywords: Transmission; Pharmacogenomics; Incipient tuberculosis; HIV; Diabetes; Biomarkers; DAIDS; Division of AIDS; NIAID; National Institute of Allergy and Infectious Diseases; NIH; National Institutes of Health; TB; tuberculosis; RePORT; Regional Prospective Ob
Keywords: pediatric; mortality; loss to follow-up; National AIDS Program; ART; Antiretroviral treatment; aSHR; Adjusted subdistribution hazard ratio; CDC; Centers for Disease Control and Prevention; NHSO; National Health Security Office; NNRTI; Non-nucleoside rever
Keywords: Flow chemistry; Microreactors; Multistep synthesis; HIV; NNRTI; Resistant virus activity; Dihydropyrimidinone;
Keywords: NNRTI; Pyridylbenzamide; Palladium-catalysed cross-coupling;
Keywords: AIDS; acquired immune deficiency syndrome; ALV; avian leukosis virus; AMV; avian myeloblastosis virus; APOBEC; apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like; ASLV; avian sarcoma leukosis virus; AZT; 3â² -azido-3â² -deoxythymidine; BIV;
Keywords: NNRTI; Molecular docking; Enrichment factor; Hydrogen bonded interaction
Keywords: API; active pharmaceutical ingredient; GRAS; generally regarded as safe; HIV-1; human immunodeficiency virus; HPLC; high pressure liquid chromatography; MSM; men who have sex with men; NNRTI; nonnucleoside reverse transcriptase inhibitor; PBMC; peripheral
Keywords: ARV; antiretroviral; ART; antiretroviral treatment; EID; Early Infant Diagnosis of HIV; HIV; Human Immunodeficiency Virus type-1; HIVDR; HIV drug resistance; NA; not applicable; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside rever
Keywords: X-ray crystallography; Fragment screening; HIV; Influenza; BpGCDH; B. pseudomallei glutaryl-CoA dehydrogenase; DHNA; 7,8-dihydroneopterin aldolase; DMSO; dimethylsulfoxide; FBDD; fragment-based drug discovery; HCV; hepatitis C virus; HIV; human immunodef
Keywords: HIV; Reverse transcriptase; Non-nucleoside reverse transcriptase inhibitors; NNRTI;
Keywords: Africa; HIV; Neuropsychiatric toxicity; NNRTI
GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus
Keywords: ABC; abacavir; ABVD; adriamycin, bleomycin, vinblastine and dacarbazine; Ara-C; cytosine arabinoside; AZT; zidovudine; BCNU; carmustine; BEACOPP; bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone; CDC; Centers fo
HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland
Keywords: PI; protease inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside reverse transcriptase inhibitor; HAART; highly active anti-retroviral therapy; TDR; transmitted drug resistance; IDU; injecting drug user; MSM; men who have se
Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients
Keywords: ARV; antiretroviral; DRM; drug resistance mutation; HAART; highly active anti-retroviral therapy; HIV; human immunodeficiency virus; NGS; next generation sequencing; NRTI; nucleos(t)idic reverse transcriptase inhibitor; NNRTI; non-nucleosidic reverse tran
High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients
Keywords: AST; aspartate transaminase; ALT; alanine transaminase; BMD; bone mineral density; BMC; bone mineral content; CTX-1; C-telopeptide of type-I collagen; DXA; dual-energy X-ray Absorptiometry; ELISA; enzyme-linked immunosorbent assay; FGF21; fibroblast growt
Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
Keywords: ART; antiretroviral therapy; TasP; Treatment-as-Prevention; NRTI; nucleoside reverse transcriptase (RT) inhibitor; NNRTI; non-nucleoside RT inhibitor; PI; protease inhibitor; INSTI; integrase strand transfer inhibitor; RAL; raltegravir; EVG; elvitegravir;
HIV and its relationship to insulin resistance and lipid abnormalities
Keywords: ABCA1; adenosine-triphosphate-binding cassette transporter A1; AIDS; acquired immunodeficiency syndrome; AMI; acute myocardial infarction; Apo-B; apolipoprotein B; cART; combined antiretroviral therapy; CRP; c-reactive protein; DM; diabetes mellitus; HDL-
Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation
Keywords: EFV; efavirenz; NNRTI; non-nucleoside reverse transcriptase inhibitor; HIV-1/AIDS; human immunodeficiency virus type 1 infection; SLS; sodium lauryl sulfate; HPC; hydroxypropylcellulose; HPMC; hydroxypropylmetilcellulose; NRTIs; nucleoside reverse transcr
Predicting CD4 count changes among patients on antiretroviral treatment: Application of data mining techniques
Keywords: CD4 count change; Antiretroviral treatment; Computational methods; Random Forest; Neural Network; J48, Decision tree; ABC; Abacavir; ddI; Didanosine; d4T; Stavudin; EFV; Efavirenz; FTC; Emotricitabine; LPV/r; Lopinavir/ritonavir; NFV; Nelfinavir; NNRTI; N
Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial
Keywords: ANC; antenatal care; ART; antiretroviral therapy; CDC; Centers for Disease Control and Prevention; eMTCT; elimination of mother-to-child HIV transmission; FGD; focus group discussion; IDI; in-depth interviews; KEMRI; Kenya Medical Research Institute; mHea
Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Keywords: NNRTI; Hybrid approach; Microwave assisted synthesis; Molecular docking; G-score; DEZVTPXFPJSDNG-UHFFFAOYSA-N; VIJXFOPOUFIAIV-UHFFFAOYSA-N; PEBAGSPBNBEURG-UHFFFAOYSA-N; PSXNTRZWHQRGKA-UHFFFAOYSA-N; DQDCNUZZSNHEIQ-UHFFFAOYSA-N; QWQAULDYHCAJNC-UHFFFAOYSA-N;
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase
Keywords: Ocimum sanctum; HIV-1; RNase H; Reverse transcriptase; Triterpenes; Ferulic acid derivatives; AIDS; Acquired Immunodeficiency Syndrome; DCM; dichloromethane; DMAP; 4-dimethylaminopyridine; DP; DNA polymerase; DQF-COSY; Double Quantum Filtered-COrrelation
Application of the Huisgen cycloaddition and ‘click’ reaction toward various 1,2,3-triazoles as HIV non-nucleoside reverse transcriptase inhibitors
Keywords: HIV reverse transcriptase; NNRTI; Lersivirine; Huisgen cycloaddition; Triazoles
The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV/AIDS patients during 1999-2012 in South Korea
Keywords: Transmitted resistance; HIV-1 pol; NRTI; NNRTI; PI;
Novel indole sulfides as potent HIV-1 NNRTIs
Keywords: HIV; NNRTI; Indole; Sulfides
Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitors
Keywords: HIV; Reverse transcriptase; NNRTI; FEP
Insights into CYP2B6-mediated drug-drug interactions
Keywords: CAR; constitutive androstane receptor; C/EBP; CCAAT/enhancer-binding protein; CHOP; cyclophosphamide-doxorubicin-vincristine-prednisone; CITCO; (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime); COUP-TF; chic
Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocket
Keywords: Piperidyl; Morpholinyl; Pyridine; Diarylpyrimidines; NNRTI; HIV; MSTDOEHPJVXRRR-UHFFFAOYSA-N; YVCSXSCQGJWNQD-UHFFFAOYSA-N; CSMNTPGYEWJYMN-UHFFFAOYSA-N; DBFPQDMRMFPDHE-UHFFFAOYSA-N; CALZUVKTPDJKNU-UHFFFAOYSA-N; SDPPJUSPVBGTAA-UHFFFAOYSA-N; KQMNRQPJUSDRIK-U
Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase
Keywords: HIV-1 reverse transcriptase; NNRTI; Structure-based drug design; Protein crystallography; Drug solubility;
NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients
Keywords: HIV; HAART; NNRTI; Radiotherapy; Cancer; Radiosensitivity;
N-Alkyl/aryl-4-(3-substituted-3-phenylpropyl)piperazine-1-carbothioamide as dual-action vaginal microbicides with reverse transcriptase inhibition
Keywords: Thiourea; NNRTI; Spermicide; Microbicide; Nonoxynol-9;
Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
Keywords: Antiviral agent; Biological activity; DAPY; NNRTI; Piperidine;
Evaluation in a clinical setting of the performances of a new rapid confirmatory assay for HIV1/2 serodiagnosis
Keywords: AHI; acute HIV infection; TAT; turnaround time; WB; western blot; NNRTI; non-nucleoside reverse-transcriptase inhibitors; PI; proteinase inhibitor; EIA; enzyme immunoassay; WHO; World Health Organization; CDC; centers for disease control and prevention; A
E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settings
Keywords: RT, reverse transcriptase; NNRTI, nonnucleoside reverse transcriptase inhibitor; RPV, rilpivirine; ETR, etravirine; EV, efavirenz; NVP, nevirapine; PrEP, pre-exposure prophylaxisHIV-1; Reverse transcriptase; NNRTI; Rilpivirine; E138A; Resistance
The phenolic metabolites of the anti-HIV drug efavirenz: Evidence for distinct reactivities upon oxidation with Frémy's salt
Keywords: Efavirenz; Phenolic metabolites; Oxidation; Quinone-imine; Quinoline; Anti-HIV drug; CYP; cytochrome P450; EFV; efavirenz; ESI; electrospray ionization; HIV; human immunodeficiency virus type 1; HPLC-DAD; high performance liquid chromatography with diod
A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy
Keywords: ART; antiretroviral therapy; WHO; World Health Organisation; PI; protease inhibitor; DBS; dried blood spot; ADR; antiretroviral drug resistance; NHLS; National Health Laboratory Service; RT; Reverse Transcriptase Coding Region of Pol Gene; NNRTI; non-nucl
Evaluation of the automatic editing tool RECall for HIV-1 pol and V3 loop sequences
Keywords: AA; amino acid; ART; antiretroviral therapy; env; envelope gene; EQA; external quality assessment; FPR; false positive rate; HIV-1; human immunodeficiency virus type 1; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transc
Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors
Keywords: APC; Allophycocyanin fluorochrome; DMSO; Dimethylsulfoxide; FITC; Fluorescein isothiocyanate fluorochrome; HAART; Highly Active Antiretroviral Therapy; II; Integrase inhibitor; MFI; Median fluorescence intensity; MDR; Multi-drug resistance; NNRTI; Non-nuc
Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility
Keywords: Anti-HIV agent; NNRTI; Drug solubility;
Analysis of primary resistance mutations to HIV-1 entry inhibitors in therapy naive subtype C HIV-1 infected mother-infant pairs from Zambia
Keywords: HIV-1; human immunodeficiency virus type 1; MTCT; mother-to-child transmission; MIP; mother-infant pair; NNRTI; non-nucleoside reverse transcriptase inhibitor; DRAM; drug resistance-associated mutation; IFA; immunofluorescence assay; PBMC; peripheral bl
Extension into the entrance channel of HIV-1 reverse transcriptase-Crystallography and enhanced solubility
Keywords: Anti-HIV agent; NNRTI; Crystal structures; Drug solubility;
Bifunctional inhibition of HIV-1 reverse transcriptase: A first step in designing a bifunctional triphosphate
Keywords: HIV-1; human immunodeficiency virus type 1; RT; reverse transcriptase; NRTIs; nucleoside RT inhibitors; NNRTIs; nonnucleoside RT inhibitors; dNTP; deoxynucleoside triphosphate; dNMP; 3â²-deoxynucleoside monophosphate; PPi; pyrophosphate; AZT; β-d-(+)-3â
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Keywords: Biotransformation; Cytochrome P450 monooxygenase; NADPH:cytochrome P450 reductase; Pharmacogenetics; Polymorphism; Xenobiotic; ADME; absorption, distribution, metabolism, excretion; ADR; adverse drug reaction; AhR; aromatic hydrocarbon receptor; CNV; copy
Rilpivirine in the light of the genotypic drug resistance data
Keywords: Rilpivirne; NNRTI; Drug resistance mutations; Antiretroviral treatment;
Lipid profile changes by high activity anti-retroviral therapy
Keywords: Lipid profile; Dyslipidaemia; Lipodystrophy; HIV; HAART; PI; NRTI; NNRTI
Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance
Keywords: Subtype C; Connection domain; NRTI; NNRTI; Drug resistance
Datos de rilpivirina en pacientes naïve. Lecciones de los estudios ECHO, THRIVE y STaR
Keywords: Tratamiento antirretroviral de inicio; Naïve; Rilpivirina; Efavirenz; Inhibidores de la transcriptasa inversa no; análogos de nucleósidos; Eficacia; Seguridad; ResistenciasRilpivirine; Efavirenz; NNRTI; NRTI; Efficacy; Safety; Virological failure; Resista